The role of SMARCB1/INI1 in development of rhabdoid tumor

被引:152
|
作者
Roberts, Charles W. M. [3 ]
Biegel, Jaclyn A. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Harvard Univ, Childrens Hosp, Dept Pediat Oncol, Dana Farber Canc Inst,Sch Med,Div Hematol Oncol, Boston, MA 02115 USA
关键词
rhabdoid tumor; retroperitoneum; angiogenesis; surgery; chemotherapy; radiotherapy; targeted therapy; recurrence; metastasis; CHROMATIN-REMODELING COMPLEX; ATYPICAL TERATOID/RHABDOID TUMORS; STRAND BREAK REPAIR; CELL-CYCLE ARREST; DNA-DAMAGE; SUPPRESSOR GENE; HSNF5/INI1; GENE; IMMUNOHISTOCHEMICAL ANALYSIS; MOLECULAR CHARACTERIZATION; FAMILIAL SCHWANNOMATOSIS;
D O I
10.4161/cbt.8.5.8019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A note about nomenclature: The ortholog of the gene mutated in rhabdoid tumors was first studied in yeast where it was identified in a screen for mutants incapable of fermenting sucrose. It was thus given the name Sucrose Non-Fermenting gene number 5 (SNF5) and was subsequently found to be a member of the SWI/SNF chromatin remodeling complex. The human ortholog of the gene was identified in a screen for proteins capable of interacting with the integrase protein of the human immunodeficiency virus and was given the name INtegrase Interactor 1 (INI1). Investigators studying a mammalian version of the Swi/Snf complex felt that its function may have diverged somewhat from the yeast complex and thus proposed renaming the complex the Brg1/Brm Associated Factors complex, or BAF complex. The rhabdoid tumor gene was thus given the name BAF47 based upon its apparent molecular mass of 47 Kd. Most recently, the genetic nomenclature committee bestowed the name SMARCB1 for SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily B, member 1. Each of these names has been used extensively in the literature and we ourselves have referred to the gene as either SNF5 (CWMR) or INI1 (JAB). In an effort to simplify communication, we have chosen to use the official SMARCB1 nomenclature here.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [21] Characterization of Thoracic SMARCB1/INI1 and ARID1A-Deficient Undifferentiated Tumor
    Chen, Chuan
    Zhu, Yi
    Sun, Tong
    Homer, Robert
    Dacic, Sanja
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1602 - S1602
  • [22] Reduced expression of SMARCB1/INI1 protein in synovial sarcoma
    Kohashi, Kenichi
    Oda, Yoshinao
    Yamamoto, Hidetaka
    Tamiya, Sadafumi
    Matono, Hiroshi
    Iwamoto, Yukihide
    Taguchi, Tomoaki
    Tsuneyoshi, Masazumi
    MODERN PATHOLOGY, 2010, 23 (07) : 981 - 990
  • [23] Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
    Mobley, Bret C.
    McKenney, Jesse K.
    Bangs, Charles D.
    Callahan, Katherine
    Yeom, Kristen W.
    Schneppenheim, Reinhard
    Hayden, Melanie G.
    Cherry, Athena M.
    Gokden, Murat
    Edwards, Michael S. B.
    Fisher, Paul G.
    Vogel, Hannes
    ACTA NEUROPATHOLOGICA, 2010, 120 (06) : 745 - 753
  • [24] Rhabdoid tumor predisposition without mutation of SMARCB1 (SNF5/INI1) in a family:: Evidence for a second genomic locus
    Fruehwald, M. C.
    Juergens, H.
    Siebert, R.
    Hasselblatt, M.
    Schneppenheim, R.
    NEURO-ONCOLOGY, 2007, 9 (02) : 187 - 187
  • [25] Oncogenic roles of SMARCB1/INI1 and its deficient tumors
    Kohashi, Kenichi
    Oda, Yoshinao
    CANCER SCIENCE, 2017, 108 (04) : 547 - 552
  • [26] SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis
    Hulsebos, T. J. M.
    Kenter, S. B.
    Jakobs, M. E.
    Baas, F.
    Chong, B.
    Delatycki, M. B.
    CLINICAL GENETICS, 2010, 77 (01) : 86 - 91
  • [27] Reduced expression of SMARCB1/INI1 protein in malignant mesothelioma
    Kawai, Toshiaki
    Kameda, Koji
    Nakashima, Hiroshi
    Hiroshima, Kenzo
    LABORATORY INVESTIGATION, 2018, 98 : 735 - 736
  • [28] Reduced expression of SMARCB1/INI1 protein in malignant mesothelioma
    Kawai, Toshiaki
    Kameda, Koji
    Nakashima, Hiroshi
    Hiroshima, Kenzo
    MODERN PATHOLOGY, 2018, 31 : 735 - 736
  • [29] Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
    Bret C. Mobley
    Jesse K. McKenney
    Charles D. Bangs
    Katherine Callahan
    Kristen W. Yeom
    Reinhard Schneppenheim
    Melanie G. Hayden
    Athena M. Cherry
    Murat Gokden
    Michael S. B. Edwards
    Paul G. Fisher
    Hannes Vogel
    Acta Neuropathologica, 2010, 120 : 745 - 753
  • [30] SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss
    Agarwal, Shipra
    Kakkar, Aanchal
    Damle, Nishikant A.
    Kumar, Chitresh
    Sarangi, Jayati
    Subudhi, Kishan
    Jain, Deepali
    Sharma, Mehar C.
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)